Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients

Leukemia. 2017 Apr;31(4):988-991. doi: 10.1038/leu.2016.385. Epub 2017 Jan 27.

D Rossille^{1

2}, I Azzaoui^{1

2}, A L Feldman³, M J Maurer⁴, G Labouré⁵, M Parrens⁵, C Pangault^{1

2}, T M Habermann⁶, S M Ansell⁶, B K Link⁷, K Tarte^{1

2}, T E Witzig⁶, T Lamy^{1

2}, S L Slager⁴, M Roussel^{1

2}, N Milpied⁵, J R Cerhan⁴, T Fest^{1

2}

¹ UMR U1236, Université de Rennes 1, INSERM, EFS, Rennes, France.
² Laboratoire d'hématologie, Pôle biologie, FHU CAMIn, CHU Rennes, Rennes, France.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
⁴ Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
⁵ Département d'hématologie, CHU Bordeaux, Université, Bordeaux, France.
⁶ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
⁷ Department of Internal Medicine, University of Iowa, Iowa City, IA, USA.

No abstract available

Publication types